Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$1.18+0.02 (+2.16%)

Close on Nov 13, 2026Market cap $15.74MP/E –Yield 0.00%

Tvardi Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2021 it was 100.0%.

Period	Period end	Value	Change (pts)
FY2021	Dec 31, 2021	100.0%	–

See a number that looks wrong?